基本信息
密理博---MILLIPORE
音標 Phonetic symbol
[ 'milip>:] 詞性及解釋 Part of speech and definition
【醫】微孔
【化】 微孔過濾
公司介紹
在美國密理博(MILLIPORE),我們專注於幫助我們的客戶解決世界上最具挑戰的人類健康問題 。作為生命科學行業的領頭羊,我們為生命科學研究和生物製藥生產提供多種學科的專業指導和全面的前沿技術、工具和服務。從我們的CEO到我們的客戶服務代表,我們的員工對工作都充滿熱情。我們和客戶一起攜手針對難題開發個性化的解決方案,在現在和將來確保科學實驗的順利進行。密理博公司是標準普爾500指數成分股之一,現有員工超過6000人,遍布全球47個國家
Advancing Life Science Together™
Research.Development.Production.
公司總部
Millipore Corporation
290 Concord Road
Billerica, MA 01821
Tel: 978-715-4321
公司創建時間: 1954
上市地點和代號: NYSE: MIL
2006年營業額: .26 billion
員工總數: 6,100 worldwide
英文介紹
Millipore (NYSE: MIL) is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world’s challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with more than 6,100 employees in 47 countries worldwide.
In 1954, a recent college graduate named Jack Bush started a membrane company that over the next 50 years would grow from a handful of employees to a multi-national bioscience corporation with more than 5,800 employees and annual sales of .3 billion. Over the years, this small company that pioneered the use of membrane technology in hundreds of diverse applications grew not only in size and sales but also in scientific capability. Through substantial R&D investments, strategic acquisitions and international expansions, Bush’s company broadened its technology and market base to become a leader in the life science industry serving biotechnology firms, pharmaceutical companies and laboratories around the world.
In the early 1950s Bush was working for the Lovell Chemical Company, a small (20 person) privately owned business just outside of Boston. One day, Lovell’s owner was approached by the U.S. Army Chemical Corps and asked to bid on a contract to develop and manufacture membrane-based filtering devices and systems used to separate the molecular components of fluid samples.
Beating out such giants as Eastman Kodak and DuPont for the government contract, this little company set to work successfully developing membranes first used in Germany after World War II, when saturation bombing resulted in widespread water contamination.
When the membranes were declassified in 1953 and offered for commercial use, Bush bought Lovell Chemical’s right to the technology for 0,000. Other companies declined to bid for the rights to this membrane technology. They believed that there was no commercial future for the membrane filter. As a result, Bush established what he called the Millipore Filter Company, named for a sponge that lives by osmosis in the Adriatic Sea. The name was later changed to Millipore Corporation to reflect its wide range of products for fluid analysis and purification.
In its early years, Millipore made some major contributions to water microbiology methods that have become part of the standard of the US Public Health Service. “The membrane technology was revolutionary in terms of giving researchers and scientists the basic tools they needed,” Bush told an interviewer in the late 1990s. “We were on the cutting edge.” Separation technologies and products were needed not only by researchers, but also by medical schools, hospitals and dialysis centers, and many industries – including the pharmaceutical, chemical, plastics, food and beverage, and microelectronics industries.
Soon after starting the company, Bush aggressively pursued new markets by establishing distributorships around the world. This was a very risky move: “I guess we believed in the bold stroke,” he reflected several years before his retirement in 1992. “We could have conserved our resources, but we decided to go hell-bent in all directions. And happily, we were lucky!” Canada was the first in 1959 and by 1961 there were distributors and sub-agents in Greece, Italy, Spain, Portugal, England, Australia, the Scandinavian countries and Switzerland. The distributorships were so successful that Bush established subsidiaries in seven countries by the end of the decade.
The company continued to expand, opening manufacturing plants in Jaffrey, New Hampshire, Molsheim France and Cork Ireland to meet the growing demand for its worldwide products.
In 2004, the company celebrated its 50th anniversary. The company continues to grow and has acquired several companies during the past few years, including NovaSeptic AB, Microsafe B.V., and Newport Biosystems.
In 2006, Millipore Corporation acquired Serologicals Corporation, a Georgia-based corporation doing business as the companies Chemicon, Upstate, Linco and Celliance. These companies provide products and services to researchers at major life science companies and leading research institutions involved in: neurology, oncology, hematology, immunology, cardiology, infectious diseases, cell signaling and stem cell research.
By integrating Serologicals’ products and services into our capabilities, Millipore has become the only company in the Life Science industry that offers both upstream cell culture and downstream separation offerings for biopharmaceutical production. The acquisition also gave Millipore leading positions in a broad range of high growth segments such as drug discovery products and services, antibodies, cell biology reagents, and stem cell research. Formerly, Serologicals products were not widely available in international markets, so Millipore’s significant presence in Europe, Asia and Japan will lead to increased sales of these products. Our customers’ research will benefit because Millipore is now able to optimize workflows from sample preparation, to developing and performing assays, to analyzing results.
With offices in more than 47 countries worldwide and more than 6,000 employees, the company is committed to helping solve the world’s challenging human health issues. Today, Millipore is a leader in the life science industry, providing scientific expertise and a full-range of products and services from concept to production.
Millipore Corporation
290 Concord Road
Billerica, MA 01821
Tel: 978-715-4321
產品目錄
-----可為以下行業提供專業的產品和解決方案
生命科學
藥物研發
樣品製備
實驗室純水
工藝最佳化
生物製品
生產過程的微生物檢測
--------------
具體分類如下:
臨床診斷&傳染性疾病
基因組
幹細胞生物學
抗體 & 免疫檢測
神經科學
細胞信號傳導&表觀遺傳學
細胞生物學
蛋白質研究
過濾&樣品製備
製藥產品分析
水相及有機溶液過濾
液體監測及工業質量控制
環境檢測和分析
色譜和質譜樣品製備
食品及飲料分析
水純化服務
水純化系統 - 反滲透水
水純化系統 - 純水
水純化系統 - 超純水
水純化耗材
水純化配件
傳統製藥
單抗 & 重組製品
疫苗
血清 & 血漿
飲料
製藥企業QA
醫院藥房
微電子行業
產品類型
對照片
Pod 過濾器
RNAi 產品
TFF 裝置和系統
一次性使用裝置
分析
動物血清
印跡膜
捲縮機
取樣板&取樣棉簽
吸液器吸管
囊式濾器
圓片濾膜
培養基
培養箱
多元設備
多孔濾膜板
套筒
完整性測試儀
密封
層析產品-生物製品
層析柱
工藝儲罐
帶菌量檢測產品
微濾產品
微生物檢測產品
快速微生物檢測系統
抑制劑
抗體
抽真空設備
抽真空設備配件
換膜式過濾器和附屬檔案
接頭&取樣口
攪拌器
攪拌式過濾器
支原體測試產品
無菌取樣系統
無菌檢測產品
有毒廢物檢測裝置
檢測裝置
水樣檢測產品
水純化服務
水純化系統-III級水 (反滲透水)
水純化系統-II級水 (純水)
水純化系統-I級水 (超純水)
水純化耗材
水純化附屬檔案
深層濾器
溶解產物(溶菌)
澄清產品
灌裝設備
環境檢測產品
生物製品服務
盒式/模組式
離心過濾單元
空氣微生物檢測產品
筒式濾器
細胞培養和診斷產品
細胞培養裝置
細胞培養設備和配件
細胞培養試劑
細胞系
細菌培養皿和含墊片培養皿
細菌檢測產品
晶片
蛋白質&酶
試劑
試劑盒
質粒
超濾產品
超濾膜
過濾系統
過濾膜
過濾裝置
過濾裝置和附屬檔案
過程檢測服務
針頭式過濾器
閥門
除病毒裝置
除菌濾器
靜態濃縮器
預濾器